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New and Noteworthy: 
This novel human study examined the effects of free fatty acid (FFA) elevation in the setting of 
hyperinsulinemia on accumulation of fat in specific types of muscle fibers. Within the context of 
the hyperinsulinemic-euglycemic clamp, we found that an increase of FFAs to a physiological 
range sufficient to reduce insulin sensitivity is associated with preferential IMCL accumulation in 
type 1 fibers.
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Abstract 
It is well described that increasing free fatty acids (FFAs) to high physiological levels 
reduces insulin sensitivity. In sedentary humans, intramyocellular lipid (IMCL) is inversely 
related to insulin sensitivity. Since muscle fiber composition affects muscle metabolism, whether 
FFAs induce IMCL accumulation in a fiber type specific manner remains unknown. We 
hypothesized that in the setting of acute FFA elevation by lipid infusion within the context of a 
hyperinsulinemic-euglycemic clamp, IMCL will preferentially accumulate in type 1 fibers. Normal 
weight participants (n=57, mean±SE: Age 24±0.6 years, BMI: 22.2±0.3 kg/m2) who were either 
endurance trained or sedentary by self-report were recruited from the University of Minnesota 
(n=31: n=15 trained) and University of Pittsburgh (n=26:n=14 trained). All participants 
underwent a hyperinsulinemic-euglycemic clamp in the context of a 6-h infusion of either lipid or 
saline-glycerol control. A vastus lateralis muscle biopsy was obtained at baseline and end-
infusion (6 hrs).  The muscle biopsies were processed and analyzed at the University of 
Pittsburgh for fiber-type specific IMCL accumulation by Oil-Red-O staining. Regardless of 
training status, acute elevation of FFAs to high physiological levels (~400-600 mEq/L) increased 
IMCL preferentially in type 1 fibers (+35±11% compared with baseline, +29±11% compared with 
glycerol control:P<0.05). The increase in IMCL correlated with decline in insulin sensitivity as 
measured by the hyperinsulinemic-euglycemic clamp (r=-0.32, p<0.01) independent of training 
status. Regardless of training status, increase of FFAs to a physiological range within the 
context of hyperinsulinemia shows preferential IMCL accumulation in type 1 fibers.  
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Abbreviations 
intramyocellular lipid (IMCL) 
free fatty acid (FFA) 
fat free mass (FFM) 
glucose infusion rate (GIR) 
lipid accumulation index (LAI) 
type 1 fibers (T1) 
type 2 fibers (T2) 
type 2a fibers (T2a) 
type 2x fibers (T2x) 
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Introduction 
Insulin resistance plays a critical role in the development of type 2 diabetes, with skeletal 
muscle the largest site of insulin resistance in the human body (35). In sedentary participants, it 
is well described that insulin resistance correlates with intramyocellular lipid (IMCL) levels (26) 
and accumulation of lipid metabolites (23, 27). It is well established that increasing free fatty 
acid (FFA) to supraphysiological levels within the context of hyperinsulinemia is associated with 
development of insulin resistance (2, 3, 23). Likewise, it has been recently shown that 
increasing FFA levels during a hyperinsulinemic-euglycemic clamp to the high physiological 
range  alters IMCL composition consistent with the FFA exposure (8) and reduces insulin 
sensitivity regardless of training status (9, 12).  
 Skeletal muscle contains both type 1 and type 2 fibers. Type 1 fibers have more IMCL 
and more mitochondria than type 2 fibers (21). Presumably, then, type 1 fibers should 
accumulate IMCL more readily than type 2 fibers in the setting of FFA exposure. However, 
whether an acute FFA elevation (9, 12) is sufficient to distribute IMCL in a fiber-type specific 
manner remains unknown.  
The impact of training on acute IMCL accumulation also remains unknown. Endurance 
training is associated with higher type 1 fiber content (11, 21, 30) and higher  IMCL in many (11, 
21, 30, 37), but not all studies (5, 17, 19). This inconsistent observation may be related to 
measuring muscle lipids by extraction (5, 19) which can be confounded by extramyocellular 
lipid. In contrast, measurement of IMCL by histology (11, 21, 30, 37) circumvents the potential 
contamination by extramyocellular lipid and additionally permits fiber type specific IMCL 
measurement. These findings provide a strong rationale to measure IMCL accumulation by 
histology to examine the effects of acute FFA elevation within the physiological range on fiber-
type specific IMCL accumulation. We hypothesized in the setting of acute FFA elevation to high 
physiological levels, IMCL will preferentially accumulate in type 1 fibers and trained participants 
will accumulate more IMCL in type 1 fibers than sedentary participants 
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Materials and Methods 
Participants  
 The studies were conducted at the University of Minnesota (n=31, n=15 trained) and 
University of Pittsburgh (n=26, n=14 trained). In total, 57 participants (n=29 trained) were used 
for analysis. At the University of Minnesota, participants were identified as “trained” if they self-
reported participation in a running program at least 45 minutes per day, 5 days per week, with a 
focused recruitment of recent (within 1 year) marathon participants. At the University of 
Pittsburgh, participants were identified as “trained” if they self-reported participation in structured 
exercise 3-5 days per week for at least 2 years with <3 yrs of interrupted training. The protocol 
for these two studies has been previously published (9, 12). Both studies were approved by the 
Institutional Review Board from their respective institutions. All participants provided written 
informed consent prior to participation. 
The studies shared the following similar features: 1) recruitment of normal weight, 
endurance-trained and normal weight, sedentary participants, 2) infusion of either lipid or 
glycerol for 6 hours in the setting of a concurrent hyperinsulinemic-euglycemic clamp, 3) 
Measurement of free mass (FFM) by DXA (GE, Fairfield CT), 4) similar protocol in preparation 
for the biopsy with participants abstaining from scheduled exercise for at least 48 hours prior to 
admission, admission the night before the biopsy visit, and remaining NPO after 10 pm until 
completion of the 2nd biopsy the next day,  5) vastus lateralis muscle biopsies prior to and after 
prolonged lipid/glycerol infusion (340-360 minutes), 6) measurement of IMCL and muscle fiber 
type at a central site (University of Pittsburgh).  
Differences between the studies include the following: 1) Study design [University of 
Minnesota: prospective interventional trial between sedentary and trained participants matched 
for age, gender and BMI, University of Pittsburgh: cross-over interventional trial between 
sedentary and trained participants]. In the design of University of Minnesota study (n=31), the 
subjects received either a lipid (n=14) or glycerol (n=17) infusion. The design of the University of 
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Pittsburgh (n=26) study enabled the analysis of IMCL accumulation with subject-specific 
declines in insulin sensitivity (Figure 3), as each subject received either a 6-hour lipid/glycerol 
infusion followed by the alternate infusion several weeks later. 2) VO2max measurement 
[University of Minnesota: treadmill, University of Pittsburgh: cycle ergometer], 3) Difference in 
measurement of insulin sensitivity [University of Minnesota, glucose infusion rate (GIR) 
calculated from a 3 hour hyperinsulinemic-euglycemic clamp at a separate visit, University of 
Pittsburgh: GIR calculated from the 6 hr hyperinsulinemic-euglycemic clamp during glycerol 
control infusion]  4) Difference in glycerol infusion [University of Minnesota: 2.25 g/100 ml at 90 
ml/hr, University of Pittsburgh: 1.7 g/100 ml at 90 cc/hr], 5) Difference in insulin exposure when 
the lipid/glycerol infusion was infused within the context of the hyperinsulinemic-euglycemic 
clamp  [University of Minnesota: 1.5 mU/kg FFM/min for 6 hours, University of Pittsburgh: 
80mU/m2/min for 6 hours]. A portion of the baseline demographics of the enrolled subjects has 
been previously published (8, 9, 12).  However, the main analysis of the paper, the effects of 
lipid infusion on fiber type specific IMCL change, remains novel and not yet published.  
FFA measurements 
 At the University of Minnesota, the nonesterified free-fatty acids (FFA) were measured 
with an enzymatic colorimetric assay (NEFA C, Wako). At the University of Pittsburgh, this was 
measured by gas chromatography flame ionization detection (24). 
Muscle biopsy technique 
 Both studies used similar techniques to obtain muscle tissue for analysis. Specifically, 
prior to the lipid/glycerol infusion, a percutaneous muscle biopsy of the vastus lateralis using a 
Bergstrom needle was performed (9, 11). Another muscle biopsy was performed at 340 – 360 
min of the lipid/glycerol infusion roughly 2 cm away from the first biopsy site. After acquisition of 
the biopsy, the tissue was trimmed of excess fat at the bedside, immediately mounted in 
Optimal Cutting Temperature compound (Fisher HistoPrep [SH75125D], Fisher Scientific, 
Waltham MA) frozen in liquid nitrogen-cooled isopentane and stored at -80°C. 
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Muscle analysis 
 Histochemical analysis was performed on serial sections using previously established 
methods at the University of Pittsburgh (11, 17). Briefly, tissue blocks from pre-and post-infusion 
were sectioned (10 µm) on a cryostat (cryotome e: Shandon Scientific) at -20°C and placed on 
individual pre-cleaned glass slides. Slides representing 45 subjects were analyzed together to 
minimize staining bias. Each analysis included data from at least 100 to 300 total fibers. Images 
were visualized using a Leica microscope (Leica DM 4000B; Leica Microsystems) at 20X, 
digitally captured (Retiga 2000R Camera; Q Imaging) and analyzed using specialized software 
(Northern Eclipse, V6.0; Empix Imaging).  For analysis of staining intensity, 4 to 5 images from 
pre- and post-infusion were captured in 16-bit grayscale and averaged. 
 Fiber type analysis: Immunohistochemistry was used to determine type 1 and type 2 
fiber types. Briefly, antibodies specific for type 1 (T1) fibers (A4.840, DSHB, U. of Iowa) or type 
2 (T2) fibers (A4.74, DSHB, U. of Iowa) were applied. Signals for specific fibers recorded using 
a fluorescein isothiocyanate excitation filter (type 1) or a tetramethylrhodamine isothiocyanate 
excitation filter (type 2a).  Type 2x fibers were assumed to be the fiber type which did not 
fluoresce with either filter. Fiber type percentages were determined from manually counting 
observed fibers used in histochemical analysis.  
 Intramyocellular lipid (IMCL) content: Lipid content was measured by Oil-Red-O staining 
(17). We calculated the Lipid Accumulation Index (LAI), which is the area stained by lipid, within 
the specific fiber type [LAI=100* [(area stained within specific fiber type)/total area of specific 
fiber type]. We also examined whether the distribution of fiber type within the sample was 
important, by calculating adjusted LAI, which adjusts for the percent distribution of the specific 
fiber type [Adjusted LAI = 100 * [(area stained within specific fiber type)/total muscle fiber area]. 
Total muscle IMCL was calculated by adding the adjusted LAI of type 1 fibers and adjusted LAI 
of type 2 fibers (15). 
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Statistical analysis 
 The results from both studies were pooled for analysis. The primary outcome was the 
change in percent IMCL staining by Oil-Red-O (LAI, adjusted LAI). A linear mixed model was 
used to analyze the results between baseline and end-infusion. We also adjusted for relevant 
covariates including the effect of pairing, infusion effects, training status (trained vs sedentary), 
fiber type, age, gender and study site. As there was no significant effect of training on the 
outcome, the trained and sedentary groups were combined and the comparison was between 
the lipid infusion vs glycerol control group. Results reported as mean±SE.  p<0.05 was 
considered significant. The Pearson correlational coefficient was used to quantify the 
association between change in insulin sensitivity and IMCL. All analyses were performed using 
Statistical Analysis Software (version 9.3, SAS Institute Inc., Cary, NC) with Tukey-Kramer 
adjustment for multiple comparisons. 
 
Results: 
Table 1 shows the baseline demographic information between trained and sedentary 
participants.  Site-specific measures were described when relevant. As all of the muscle 
biopsies had muscle fiber typing and lipid quantification performed at the same site (University 
of Pittsburgh), these results were combined. As the FFA results were not significantly different 
between the 2 sites, the results were combined as well. 
Compared with the sedentary participants, the trained participants were slightly older, 
with higher absolute VO2 max (ml/min) and relative VO2 max (ml/FFM/min). FFA levels were 
similar between the trained and sedentary groups at baseline (Table 1). At the end of the lipid 
infusion, the FFA levels were in the high physiological range (489 – 641 uM)  which was slightly 
higher in the sedentary group (p=0.05). Insulin sensitivity, as measured by the GIR at the end of 
the hyperinsulinemic-euglycemic clamp, was higher in the trained participants than sedentary 
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participants. Compared with sedentary participants, trained participants had more type 1 fibers, 
less type 2 fibers, and specifically less type 2x fibers.  Regardless of training status, each group 
had more type 2 fibers (52%-63% area stained) than type 1 fibers (37-48% of area stained). 
Regardless of training status, type 1 fibers had significantly more lipid (as measured by LAI  or 
adjusted LAI) than the other fiber types. This is relevant as LAI and adjusted LAI are 
physiologically different. LAI uses the specific fiber type (i.e Type 1 fibers) area as the 
denominator. Adjusted LAI uses the total muscle fiber area (i.e sum of all muscle fibers) as the 
denominator. 
 In particular, type 1 fibers from trained participants had significantly less lipid (LAI: 
38.3%±3.3) than sedentary participants (LAI: 51.3%±4.0). However, the contribution of lipid in 
type 1 fibers to overall muscle lipid content (adjusted LAI) remained similar as trained 
participants had more type 1 fibers (% type 1 fibers: 47.5±3.6) than sedentary participants (% 
type 1 fibers: 36.5±2.0).  As sedentary participants had more type 2x fibers (% type 2x fibers: 
20±2.0) than trained participants (% type 2x fibers: 9.0±2.2), sedentary participants had higher 
contribution of lipid in type 2x fibers to overall muscle lipid content (adjusted LAI: 5.7±1.0) than 
trained participants.(adjusted LAI: 1.6±0.2) Total IMCL between trained and sedentary 
participants (adjusted LAI of type 1 fibers + adjusted LAI of type 2 fibers) was not different 
between trained and sedentary participants. 
We examined whether fitness, as quantified by tertiles of VO2max, might influence fiber 
specific IMCL accumulation. We accommodated for differences in VO2 max measurement 
between sites by designating the highest tertile of site-specific VO2 max of group as “fit” and the 
lowest tertile of site-specific VO2 max of group as “unfit.” As no significant interaction between 
fitness and IMCL accumulation was noted, the results from the trained and sedentary groups 
were pooled in the final analysis 
Effects of acute FFA on Total IMCL accumulation 
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 As noted in Figure 1, lipid infusion was significantly increased total IMCL by 22.8% 
(p<0.05). Glycerol infusion did not alter total IMCL levels. To generate Figure 1, all subjects 
who received a glycerol infusion (n=43) and all subjects who received a lipid infusion (n=40) 
were used. 
Effect of acute increase in FFA on fiber type specific IMCL accumulation 
Representative images of IMCL (Oil-Red-O) levels before (Figure 2A) and after a 6-hour 
glycerol infusion (Figure 2B) or 6-hour lipid infusion (Figure 2C) are shown in Figure 2.  
Specific fiber types (type 1 fibers in Red, type 2 fibers in Green) are identified (Figure 2D-E).   
Figure 2G and 2H quantifies the fiber type (T1, T2, T2a, T2x) specific IMCL content 
before and after a 6-hour lipid or glycerol control infusion. To generate Figure 2, all subjects 
who received a glycerol infusion (n=43) and all subjects who received a lipid infusion (n=40) 
were used. At baseline, type 1 fibers had significantly more lipid, as measured by LAI or 
adjusted LAI, than the other fiber types. In the setting of acute FFA elevation from the lipid 
infusion, IMCL (LAI) increased specifically in type 1 fibers compared with baseline levels 
(+35±11%, p<0.05) or the equivalent glycerol control (+29±11%, p<0.05) (Figure 2G). In 
contrast, the glycerol infusion did not alter IMCL content. With lipid infusion, the adjusted LAI 
(Figure 2H) did not significantly increase for the different fiber types, although the trend was 
positive for increased adjusted LAI in type 1 fibers (p=0.02 unadjusted for multiple comparisons, 
p=0.19 adjusted for multiple comparisons).  
We examined the correlation between fiber-type specific IMCL accumulation and insulin 
sensitivity (as measured by GIR) using University of Pittsburgh specific data (n=26).  This was 
possible as the cross-over study design (lipid vs glycerol infusion) enabled the direct 
comparison of IMCL accumulation on insulin sensitivity within the same subject.  There was a 
significant correlation between change in % area stained by IMCL in type 1 fibers and 
decreasing insulin sensitivity (r=-0.48, p=0.05) (Figure 3 A), which was not significant for type 2 
fibers (-0.26, p=0.29), type 2A fibers (-0.30, p=0.22), or type 2x fibers (-0.25, p=0.49). Likewise, 
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there was a significant correlation between increasing % adjusted area stained by IMCL from 
type 1 fibers and decreasing insulin sensitivity (r=-0.52 p=0.03)  (Figure 3 B), which was not 
significant for type 2 fibers (-0.26, p=0.29), type 2A fibers (-0.41, p=0.11), or type 2x fibers (0.09, 
p=0.77). 
 
Discussion 
The objective of this study was to examine the effects of increasing free fatty acid (FFA) 
levels to the high physiological range within the context of a hyperinsulinemic-euglycemic 
clamp, on fiber type specific intramyocellular lipid (IMCL) accumulation. The main finding was 
that FFA elevation by lipid infusion increases IMCL specifically in type 1 fibers of both trained 
and sedentary subjects, which is associated with a reduction in insulin sensitivity. These 
findings suggest that IMCL accumulation in Type 1 fibers may be a compensatory response 
when FFA is preferentially used over glucose.      
There may be several mechanisms driving the observed IMCL accumulation, particularly 
in type 1 fibers. In our study design, FFA exposure is combined with insulin infusion. Insulin 
enhances fatty acid uptake into the muscle (28). Fatty acids enter muscle fibers by fatty acid 
transport proteins such as fatty acid translocase (FAT)/CD36 (28), plasma membrane 
associated fatty acid binding protein (FABPpm) and fatty acid transport proteins 1-6 (FATP1-6) 
(33). In humans, type 1 fibers are enriched in FAT/CD36 (39). In rats, higher levels of 
FAT/CD36 were observed in red muscle than white muscle, paralleling elevated rates of fatty 
acid transport in red muscle than white muscle (7). Although it is well established that type 1 
fibers have higher IMCL than other muscle fibers (18), we make the novel observation that 
acute FFA elevation is sufficient to promote preferential accumulation of  IMCL in type I fibers. 
These findings may be influenced by the context of our hyperinsulinemic-euglycemic clamp. 
Although muscle cells exposed to insulin and glucose increase triglyceride synthesis and 
reduce triglyceride hydrolysis (20), this might not be seen in vivo as hyperinsulinemia reduces 
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plasma FFA levels as reported by our group(9) and others.(22)  In the current study, FFA and 
glycerol were supplied at a high physiological level within  the context of hyperinsulinemia, 
likely enhancing the observed IMCL accumulation compared with FFA infusion alone . We 
acknowledge that further delineation of the relative role of FFA infusion on IMCL accumulation 
would require a lipid infusion without hyperinsulinemia and preferably with the use of stable 
isotopes to identify the contribution of IMCL synthesis (1).  
We examined whether a history of training may influence our results. Aerobically trained 
participants have more type 1 fibers than sedentary participants.(14) In addition, in the setting 
of hyperinsulinemia, trained participants have higher influx of FFA into muscle than sedentary 
participants.(22) Consequently, we hypothesized a potential training effect with trained 
participants having greater increase in total IMCL than sedentary participants. This was not 
observed in the current study. There are several potential reasons. The similar accumulation of 
IMCL in type 1 fibers regardless of training status suggests that training might not alter resting 
fatty acid transport at the fiber level. This is supported by the observation that FAT/CD36 and 
FATP1 protein were not different between trained cyclists vs patients with diabetes or 
sedentary controls (29), although we acknowledge that effect of training on the different muscle 
fatty acid transport proteins depends greatly on the training program (6, 25, 36, 38). 
Alternatively, in trained participants, increased fatty acid uptake in type 1 fibers may be 
paralleled by increased IMCL turnover, resulting in similar IMCL levels compared with 
sedentary participants. In support of this alternative explanation, we had previously shown in 
this cohort that acute FFA elevation increased diacylglycerol, a lipotoxic metabolite, in 
sedentary participants but not trained participants (8). Likewise, we had previously shown that 
lipid infusion was associated with higher fat oxidation in trained participants than sedentary 
participants, suggesting improved metabolic flexibility (12). Lastly, our muscle samples 
regardless of training status, had more type 2 fibers than type 1 fibers. This higher proportion of 
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type 2 fibers relative to type 1 fibers might blunt the training related effect on total IMCL 
accumulation. 
The accumulation of IMCL in type I fibers inversely correlated with insulin sensitivity. 
This was not seen in type 2 fibers. One potential explanation might be that FFA alters type I 
fiber metabolism to reduce insulin sensitivity. However, we had previously observed that lipid 
infusion did not affect p-Akt, a critical insulin signaling molecule (12). A more likely explanation 
is that FFA reduction in insulin sensitivity is paralleled by increasing IMCL storage in type I 
fibers, potentially as a compensatory mechanism. It is well established that acute FFA elevation 
increases total IMCL and reduces muscle glucose uptake (10). This FFA induced reduction in 
muscle glucose uptake has been attributed to reduced glucose oxidation (31) and  reduced 
glucose transport (32). Specific to the current study,  we had previously shown  that acute lipid 
oversupply reduced glucose uptake (9, 12)  due to reductions in carbohydrate oxidation with 
variable effects on nonoxidative glucose disposal depending on training status (12). 
Consequently, our observed acute lipid accumulation in type I fibers may reflect compensatory 
storage to preserve metabolic benefit in the setting of repeated lipid oversupply. As training 
tends to increase total IMCL while preserving insulin sensitivity, an explanation for this apparent 
“athlete’s paradox” may be related to type I specific changes beyond IMCL accumulation, with a 
need for future studies to focus on lipid droplet organization and dynamics (4, 13, 34). 
It is important to understand our results within the context of current literature. 
Previously, it has been reported that IMCL is generally about 1-3% of total area (15, 16).  This 
discrepancy with our current findings (~30%) is likely related to the limitations of the ORO 
technique. The ORO technique is a semiquantitative measure and is best for comparison 
between groups within the same study. The previous work (15, 16) captured the image using an 
8-bit gray scale, which represents 256 shades of gray. Our current study used a 16-bit gray 
scale, which represents 65000 shades of gray, allowing for greater sensitivity for IMCL staining. 
Additional refinements in software (Northern Eclipse currently vs Image J previously) permitted 
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adjustment in background light and direct measurement of cross-sectional area in microns to 
augment sensitivity, such that our reported IMCL levels are roughly 10X higher than previously 
reported (15, 16). We acknowledge that our IMCL results are not directly comparable with 
previous literature due to differences in technique. Nevertheless, our results remain applicable 
for comparison within the same study. We found a significant increase in lipid content of type 1 
fibers when measured by LAI (relative to type 1 fibers) and a trend to increase in type 1 fibers 
when measured by adjusted LAI (relative to the total muscle area). We believe that this 
“blunting” of IMCL accumulation in type 1 fibers, as measured by adjusted LAI, is due to the 
presence of more type 2 fibers, relative to type 1 fibers as described in Table 1. 
 Our study has several strengths. This includes the following: 1) overall size of the cohort 
(n=57) receiving lipid infusion or matched glycerol control, 2) study design incorporating paired 
analysis, and 3) measurement of IMCL and muscle fiber type at a central site (University of 
Pittsburgh). Potential limitations include the following: 1) Slight differences in study design 
[Minnesota: cross-sectional design with matched controls, Pittsburgh: cross-over study], 2) 
Slight differences in the lipid and glycerol infusions between study sites which are addressed by 
the paired analysis in the study design, 3) Slight differences in design of the hyperinsulinemic – 
euglycemic clamp  to measures insulin sensitivity, although the GIR was not significantly 
between the 2 sites  and was consistently higher in trained than sedentary people, regardless of 
site, 4) Selection of trained participants based on self-report, as the VO2 max testing shows a 
significant, albeit only slightly higher, fitness in trained vs sedentary participants from Minnesota. 
This may explain our observation that total IMCL was not statistically higher in trained than 
sedentary participants, as previous literature recruited more highly trained participants (~VO2 
max 4200-4600 ml/min) (15) than the current study (~VO2 max 2600-3800 ml/min), 5) Despite 
the groups having similar baseline BMI and FFA, the post-infusion FFA was higher in the 
sedentary group than trained group. Potentially, this difference in post-infusion FFA level may 
impact IMCL accumulation between trained and sedentary groups, although no statistically 
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significant differences were observed, 6) As discussed earlier, the effect of the concurrent 
hyperinsulinemic-euglycemic clamp needs to be acknowledged. The presence of the clamp 
likely augmented IMCL accumulation compared to acute FFA elevation without concurrent 
hyperinsulinemia. Lastly, as our study design focused on acute FFA elevation, the extent to 
which our findings translate to chronic FFA elevation remains unknown. 
 In conclusion, within the context of the hyperinsulinemic-euglycemic clamp, we found 
that an increase of FFAs to a physiological range sufficient to reduce insulin sensitivity is 
associated with preferential IMCL accumulation in type 1 fibers. 
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Table and Figure legends: 
Table 1: Baseline characteristics of study participants 
57 participants were available for analysis. These were derived from the University of Minnesota 
(n=31, n=15 trained) and University of Pittsburgh (n=26, n=14 trained).  
Results are reported as mean (±SE) if a continuous variable. Abbreviations: free fatty acids 
(FFA), fat free mass (FFM), glucose infusion rate (GIR), % area stained by lipid (LAI). 
 *  indicates significant difference (p<0.05) compared with other fiber types within same training 
status 
LAI = 100* [area stained within specific fiber type/total area of specific fiber type] 
Adjusted LAI = 100 * [area stained within specific fiber type/total muscle fiber area] 
 
Figure 1: Acute free fatty acid elevation increases total IMCL.  
Total IMCL (% of muscle stained) increased with lipid infusion.  * indicates p<0.05. Results 
presented as mean±SE. To generate this figure, all subjects who received a glycerol infusion 
(n=43) and all subjects who received a lipid infusion (n=40) were used. From the University of 
Minnesota,  subjects received either a lipid (n=14) or glycerol (n=17) infusion in a prospective 
design. From the University of Pittsburgh, subjects (n=26) received both a lipid and glycerol 
infusion in a cross-over design. 
 
Figure 2: Acute free fatty acid elevation preferentially increases IMCL in type I fibers. 
Representative images of IMCL staining before and after 6-hour lipid exposure. 
Vastus lateralis muscle was stained for IMCL using Oil-Red-O at baseline (Panel A), after 6 
hours of glycerol exposure (Panel B), and  after 6 hours of lipid exposure (Panel C). The muscle 
was then stained for type 1 fibers (red stain) and type 2 fibers (green stain) (Panel D - F). 
Images are at 20X magnification. Panel G shows the percent area stained by lipid within the 
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specific fiber type. Panel H shows the percent area stained by lipid after adjustment for percent 
distribution of specific fiber type. 
 
Notable findings include :1) Panel G: type 1 fibers having higher lipid content and a significant 
increase in percent area stained in the setting of  FFA elevation, 2) Panel G and H: no 
significant change in lipid content with glycerol infusion, 3) Panel H: Lower IMCL in type 2x 
fibers when adjusting for percentage of type 2x fibers which did not change with either lipid or 
glycerol infusion, 4) Panel H: No change in adjusted lipid area for type 1 fibers given FFA 
elevation, although there is a trend towards significance. 
To generate this figure, all subjects who received a glycerol infusion (n=43) and all subjects who 
received a lipid infusion (n=40) were used. 
Results are presented as mean±SE 
*indicates significant compared with baseline 
# indicates significant compared with glycerol at end infusion 
+ indicates significant compared with other fibers at same time point and same infusion 
exposure with exceptions noted 
 
Figure 3: IMCL accumulation in type 1 fibers inversely correlates with insulin sensitivity. 
Panel A shows a significant correlation between the decline in insulin sensitivity and increasing 
area stained by IMCL within type 1 fibers (LAI). Panel B shows a similar finding. Here, the 
decline in insulin sensitivity correlates inversely with change in area stained by IMCL after 
adjustment for percent distribution of type 1 fibers (adjusted LAI). Only data from the University 
of Pittsburgh (n=26) is presented, as the cross-over study design (lipid vs glycerol infusion) 
enabled the direct comparison of IMCL accumulation on insulin sensitivity within the same 
subject.  
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Table: 1 
Characteristic       Trained (n=29) Sedentary (n=28) P value 
Female/Male 13/16 13/15 0.90 
Age (years) 25.9 (0.9) 22.6 (0.6) <0.01 
Body Mass Index (kg/m2) 22.1 (0.4) 22.3 (0.4) 0.72 
VO2 max 
Absolute treadmill VO2max (ml/min) 
(Minnesota) 2601.8 (217.1) 1730.7 (108.5) <0.01 
Treadmill VO2max (ml/kg FFM/min) 
(Minnesota) 61.6 (1.4) 55.8 (1.6) 0.01 
Absolute cycling VO2max (ml/min) 
(Pittsburgh)  3815.7 (290.7) 2640.5 (192.6) <0.01 
Cycling VO2max (ml/kg FFM/min) 
(Pittsburgh)  70.7 (2.3) 52.6 (1.8) <0.01  
Free fatty acid levels 
Baseline  (uM) 
 386 (55) 430 (38) 0.51 
End of lipid infusion (uM) 
 489 (44) 641 (62) 0.05 
Insulin sensitivity 
Glucose infusion rate 
 (GIR: mg glucose infused/kg FFM/min 
at the end of a 3 hr clamp) 
(Minnesota)  
12.2 (0.8) 9.1 (0.6) <0.01 
Glucose infusion rate 
 (GIR:  mg glucose infused/kg FFM/min 
at the end of a 6 hr clamp) 
(Pittsburgh) 
 
13.4 (0.5) 10.7 (1.0) 0.02 
Muscle fiber type    
type 1 fibers (%) 47.5 (3.6) 36.5 (2.0) 0.01 
type 2 fibers (%) 52.4 (3.6) 63.5 (2.0) 0.01 
type 2a fibers (%) 44.3 (3.0) 43.4 (1.5) 0.80 
type 2x fibers (%) 9.0 (2.3) 20 (2.0) < 0.01 
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Fiber type specific lipid staining  (LAI) 
% of type 1 fibers (au) 38.3 (3.3)* 51.3 (4.0)* 0.01 
% of type 2 fibers (au) 29.4 (2.2) 28.8 (2.9) 0.88 
% of type 2a fibers (au) 29.7 (2.1) 28.6 (2.4) 0.72 
% of type 2x fibers (au) 28.1 (3.6) 31.8 (0.1) 0.60 
Fiber type specific lipid staining, considering fiber type distribution within sample (Adjusted LAI) 
% of   type 1 fibers (au) 18.5 (2.3)* 18.6 (2.0)* 0.97 
% of   type 2 fibers (au) 13.0 (1.0) 15 (1.6) 0.28 
% of  type 2a fibers (au) 12.0 (1.1) 13.0 (1.4) 0.59 
% of  type 2x fibers (au) 1.6 (0.2) 5.7 (1.0) <0.01 
Total IMCL in muscle (adjusted LAI type 
1 fibers+adjusted LAI type 2 fibers) 31.4 (2.4) 30.9 (2.4) 0.89 
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Figure 1:  
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